Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02021071 · ClinicalTrials.gov registry record
Virtual Path Planning for Image-guided Needle Interventions
A clinical trial, sponsored by Philips Clinical & Medical Affairs Global.
- Completed
- Registry status
- 24
- Enrollment target
NCT02021071 is a clinical trial that has completed, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 24 participants.
The verdict
NCT02021071 has completed, sponsored by Philips Clinical & Medical Affairs Global.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
Philips Healthcare has added a virtual path planner to the current commercially available XperGuide software platform and that has the potential to significantly reduce dose during image-guided needle interventions.
Interventions
- RADIATION XperGuide
- RADIATION XperGuide with virtual path planning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02021071
The ClinicalTrials.gov registry entry for NCT02021071 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Clinical & Medical Affairs Global, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which XperGuide is the first listed.
NCT02021071 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02021071 about?
NCT02021071 is a clinical study titled "Virtual Path Planning for Image-guided Needle Interventions". Philips Healthcare has added a virtual path planner to the current commercially available XperGuide software platform and that has the potential to significantly reduce dose during image-guided needle interventions.
What is the current status of trial NCT02021071?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2013-12. Estimated completion is 2014-06.
What interventions are being tested in trial NCT02021071?
The interventions under investigation include: XperGuide (RADIATION), XperGuide with virtual path planning (RADIATION).
Who is sponsoring clinical trial NCT02021071?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.